Navigation Links
Insulet Reports First Quarter 2008 Results
Date:5/13/2008

or should any of its assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Insulet undertakes no obligation to publicly update or revise any forward-looking statements.

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

Contact:

Stephanie Marks for Insulet Corporation

ir@insulet.com

877-PODD-IR1 (877-763-3471)

INSULET CORPORATION

Selected Financial Data

CONSOLIDATED STATEMENTS OF OPERATIONS DATA:

Three Months Ended

March 31,

2008 2007

(In thousands, except share and

per share data)

(Unaudited)

Revenue $ 6,671 $ 2,008

Cost of revenue 9,998 4,572

Gross loss (3,327) (2,564)

Operating expenses:

Research and development 2,923 2,470

General and administrative 5,197 2,660


'/>"/>

SOURCE Insulet Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
2. Insulet Corporation to Report Fourth Quarter and Full Year 2007 Financial Results on Monday, March 17
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... This webinar will examine the ... promotion, and review the basic FDA regulations and ... apply these principles through real world case studies ... fundamentals on FDA regulations and guidance related to ...     Assessing traditional and newer forms of promotional materials ...
(Date:6/18/2013)... Texas , June 18, 2013   ... ), a biopharmaceutical company focused on discovering breakthrough ... John Northcott has joined the company as ... operations. Mr. Northcott brings extensive commercial experience to ... across a variety of therapeutic areas. ...
(Date:6/18/2013)... WA (PRWEB) June 18, 2013 Though ... -- 11,000, according to the U.S. Bureau of Labor Statistics ... increase of 24,000 per month. Most new health care jobs ... the hospital sector saw a loss of 6,000 jobs. Overall, ... outplacement consultancy firm Challenger, Gray & Christmas reported that a ...
(Date:6/18/2013)... PathoGenetix, Inc. , a commercial-stage ... strain typing, announced today that John A. Luckey, ... President of Engineering. Dr. Luckey will lead technology ... Microbial Genotyping System . The fully automated RESOLUTION ... kits, database and software, will be commercially available ...
Breaking Biology Technology:Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3
... Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading ... and stem cell research systems, today announced positive ... These validation results were presented today by ... University of Pittsburgh School of Medicine as ...
... Calif., Feb. 25 Cord Blood America, Inc. ... stem cell preservation company ( http://www.cordblood-america.com ) focused ... cells to families nationwide and internationally, today announced ... restructure its current outstanding debt."The restructuring is a ...
... development of CureDM,s HIP2B peptide targeted for the treatment of type 1 ... ... 2009 -- Calvert Research, LLC (a Calvert Holdings, Inc. ... CureDM to continue the preclinical development of CureDM,s HIP2B peptide. Calvert ...
Cached Biology Technology:Data on WaferGen's SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference 2Data on WaferGen's SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference 3Data on WaferGen's SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference 4Data on WaferGen's SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference 5Cord Blood America Restructures Debt; Projects to be Cash Flow Positive 2Calvert Research and CureDM Sign Collaborative Agreement 2Calvert Research and CureDM Sign Collaborative Agreement 3
(Date:6/16/2013)... FRANCISCO (June 16, 2013)Male mice who were fed a ... father offspring who also had higher levels of body ... effect was observed primarily in male offspring, despite their ... the annual meeting of The Endocrine Society in San ... that may affect metabolism and behavior of offspring dependent ...
(Date:6/16/2013)... years ago triggered a similar marine ecosystem crisis to ... global warming, according to research published today in ... the universities of Newcastle, UK, Cologne, Frankfurt and GEOMAR-Kiel, ... in the marine ecosystem during the mid-Cretaceous greenhouse period. ... the amplitude and duration of the temperature change.,Analysing the ...
(Date:6/14/2013)... Many students have difficulty understanding and explaining how ... teach the subject, researchers at Michigan State University ... from the molecular changes underlying an evolving characteristic ... The researchers, Peter J. T. White, Merle K. ... of the scenarios into a cellular and molecular ...
Breaking Biology News(10 mins):Obese male mice father offspring with higher levels of body fat 2Global cooling as significant as global warming 2Teaching complete evolutionary stories increases learning 2
... cancers account for more than 1 million deaths worldwide ... to identify the molecular events that result in the ... established that interfering with the function of one gene, ... on the cells lining the innermost layer of the ...
... research study identifies a critical inhibitory step that ... regulating the balance between neutrophil production and destruction. ... Immunity, suggests that the process for disposal of ... A clear understanding of the processes that control ...
... disease in which cells in the bone marrow grow and ... (leukemic). The progression of the disease is slow and there ... production of CLL cells, and the time-course of their death. ... a static disease of long-lived lymphocytes -- that the leukemia ...
Cached Biology News:Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer 2White blood cell waste disposal system plays critical regulatory role 2The very unexpected life and death of a leukemic cell 2
Blue Standard is 3-cyano-7-hydroxycoumarin....
Cyan Standard is 7-hydroxy-4-trifluoromethylcoumarin...
6-(2,4-dinitrophenyl)aminohexanoic acid, succinimidyl ester (DNP-X, SE)...
Endothelin-converting enzyme 1 (EC 3.4.24.71) (ECE-1). [Source:Uniprot/SWISSPROT;Acc:P42892] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: